Simulation of pharmacological results.

JM John G. Mikhael
SG Samuel J. Gershman
request Request a Protocol
ask Ask a question
Favorite

Update over the course of a single trial occurred according to the approximation in Eq. 7. To visually match the deviation of responses in medicated conditions from those of placebo, we have arbitrarily scaled the total update by αη = 20 (note that αη need not be <1) and set σ = 5 and Tmax = 35 for the placebo condition. For the temporal estimates, we have plotted xt=7 and xt=17. We take the end point of temporal reproduction to occur at the peak of V̂τ. For administration of DA agonists, we have chosen a gain modulation of 5 for positive RPEs and 0.2 for negative RPEs; for administration of DA antagonists, we have chosen a gain modulation of 0.2 for positive RPEs and 5 for negative RPEs. Finally, we have fixed the veridical time estimate to correspond to the baseline condition of unitary modulation of all RPEs (see Fig. 7).

Results from pharmacology compared with model behavior. A: in Lake and Meck (2013), subjects reproduced previously learned 7-s and 17-s intervals after administration of the dopamine (DA) agonist amphetamine (AMP), the DA antagonist haloperidol (HAL), or placebo. In the majority of subjects, amphetamine reduced response time, whereas haloperidol delayed it. Reprinted from Lake and Meck (2013) with permission from Elsevier. B: our model recapitulates these effects. See methods for simulation details.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A